Oncology & Cancer
Possible treatment for serious blood cancer
A single antibody could be the key to treating multiple myeloma, or cancer of the blood, currently without cure or long-term treatment.
May 6, 2013
0
0
Multiple Myeloma
Oncology & Cancer
Searching for therapeutic synergy in primary effusion lymphoma
Primary effusion lymphoma (PEL) is a rare, fatal form of aggressive B-cell lymphoma caused by Kaposi's sarcoma-associated herpesvirus (KSHV). The disease most commonly occurs in immunocompromised patients, such as those with ...
May 1, 2013
0
0
Oncology & Cancer
TGen professor discusses benefits of whole genome sequencing in study of multiple myeloma
The scientific benefits of whole genome sequencing at the Translational Genomics Research Institute (TGen) will be presented at the 14th International Myeloma Workshop, April 3-7 at the Kyoto International Conference Center.
Apr 3, 2013
0
0
Oncology & Cancer
New multiple myeloma treatment guidelines personalize therapy for patients
Researchers at Mayo Clinic Cancer Center have developed new guidelines to treat recently diagnosed multiple myeloma patients who are not participating in clinical trials. The guidelines give physicians practical, easy to ...
Apr 1, 2013
0
0
Medical research
When bone-eating cells gain the upper hand
Advanced osteoporosis is often the most severe sequela, or resulting condition, of plasma cell cancer (multiple myeloma). Abnormally functioning stem cells are a key causal factor.
Mar 11, 2013
0
0
.jpg)
Oncology & Cancer
Novel treatment for bone marrow cancer
Multiple myeloma is a form of cancer in which the plasma cells in the bone marrow grow out of control, causing damage to bones as well as predisposing patients to anaemia, infection and kidney failure. A medical procedure ...
Mar 7, 2013
0
0
Medical research
A better bone marrow transplant: Preventing graft-versus-host disease
Bone marrow transplant is a key treatment for patients with leukemia, lymphoma, multiple myeloma and other blood disorders.
Mar 1, 2013
0
0
Medical research
Distinct niches in bone marrow nurture blood stem cells
In research that could one day improve the success of stem cell transplants and chemotherapy, scientists have found that distinct niches exist in bone marrow to nurture different types of blood stem cells.
Feb 24, 2013
0
0
Oncology & Cancer
New compound holds high promise in battling kidney cancer
Chemists at the University of California, Riverside have developed a compound that holds much promise in the laboratory in fighting renal (kidney) cancer.
Feb 19, 2013
0
0
Medications
Pomalyst approved for advanced multiple myeloma
(HealthDay)—Pomalyst (pomalidomide) has been approved by the U.S. Food and Drug Administration to treat cases of multiple myeloma that have not responded to other therapies.
Feb 9, 2013
0
0
